RPLP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.64435132177232E-12 |
Normal-vs-Stage2 |
3.57319951405088E-10 |
Normal-vs-Stage3 |
1.62458935193399E-12 |
Normal-vs-Stage4 |
1.96287430753728E-13 |
Stage1-vs-Stage2 |
5.661800E-01 |
Stage1-vs-Stage3 |
1.078570E-01 |
Stage1-vs-Stage4 |
7.802100E-03 |
Stage2-vs-Stage3 |
4.563500E-02 |
Stage2-vs-Stage4 |
1.623220E-03 |
Stage3-vs-Stage4 |
8.523900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.6242562850266E-12 |
Normal-vs-AfricanAmerican |
1.42050005091932E-09 |
Normal-vs-Asian |
1.180360E-01 |
Caucasian-vs-AfricanAmerican |
4.944400E-01 |
Caucasian-vs-Asian |
4.131600E-01 |
AfricanAmerican-vs-Asian |
2.146600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62447832963153E-12 |
Normal-vs-Female |
1.62436730732907E-12 |
Male-vs-Female |
5.177700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.00579999995354E-06 |
Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
Normal-vs-Age(81-100Yrs) |
1.788150E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.336800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.537200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.109000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.645950E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.052000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.219000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.38499999996689E-06 |
Normal-vs-Grade 2 |
4.6296300126869E-14 |
Normal-vs-Grade 3 |
<1E-12 |
Normal-vs-Grade 4 |
8.67028671081016E-12 |
Grade 1-vs-Grade 2 |
6.726400E-02 |
Grade 1-vs-Grade 3 |
2.109600E-01 |
Grade 1-vs-Grade 4 |
3.262500E-03 |
Grade 2-vs-Grade 3 |
6.451200E-01 |
Grade 2-vs-Grade 4 |
1.041180E-01 |
Grade 3-vs-Grade 4 |
2.846300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
<1E-12 |
Normal-vs-ccB subtype |
<1E-12 |
ccA subtype-vs-ccB subtype |
6.340600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.7715611723761E-15 |
Normal-vs-N1 |
2.479000E-03 |
N0-vs-N1 |
5.217800E-01 |
|
|